Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-16-150960
Filing Date
2016-11-17
Accepted
2016-11-17 17:41:00
Documents
1
Period of Report
2016-11-15

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 7541
  Complete submission text file 0001209191-16-150960.txt   9082
Mailing Address C/O BIOENVISION, INC. 345 PARK AVENUE, 41ST. FLOOR NEW YORK NY 10154
Business Address
Scibetta James S (Reporting) CIK: 0001383242 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35060 | Film No.: 162005923

Mailing Address 5 SYLVAN WAY SUITE 300 PARSIPPANY NJ 07054
Business Address 5 SYLVAN WAY SUITE 300 PARSIPPANY NJ 07054 973-254-3560
Pacira Pharmaceuticals, Inc. (Issuer) CIK: 0001396814 (see all company filings)

EIN.: 510619477 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations